Apotea AB (publ) (CHIX:APOTES) ROC (Joel Greenblatt) %: 39.97% (As of Mar. 2026) — 22% Above Median


CHIX:APOTES Apotea AB (publ) CHIX:APOTES
18 GF Score
Price kr65.20
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) ROC (Joel Greenblatt) %?

Apotea AB (publ) CHIX:APOTES 18 ROC (Joel Greenblatt) % is 39.97% as of Mar. 2026, which is 22% above its 10-year median of 32.86. GuruFocus rates CHIX:APOTES with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 669 Healthcare Providers & Services companies, Apotea AB (publ) ranks better than 74.59% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Apotea AB (publ)'s annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 39.97%.

The historical rank and industry rank for Apotea AB (publ)'s ROC (Joel Greenblatt) % or its related term are showing as below:

CHIX:APOTEs' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 7.53   Med: 32.86   Max: 40.1
Current: 32.3

During the past 5 years, Apotea AB (publ)'s highest ROC (Joel Greenblatt) % was 40.10%. The lowest was 7.53%. And the median was 32.86%.

CHIX:APOTEs's ROC (Joel Greenblatt) % is ranked better than
74.59% of 669 companies
in the Healthcare Providers & Services industry
Industry Median: 12.46 vs CHIX:APOTEs: 32.30

Apotea AB (publ)'s 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Apotea AB (publ)  (CHIX:APOTEs) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Apotea AB (publ) ROC (Joel Greenblatt) % Related Terms


Apotea AB (publ) ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Apotea AB (publ)'s ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apotea AB (publ) ROC (Joel Greenblatt) % Chart

Apotea AB (publ) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
37.66 7.53 19.65 40.10 32.86

Apotea AB (publ) Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.69 40.54 39.21 10.16 39.97

Apotea AB (publ) ROC (Joel Greenblatt) % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Apotea AB (publ)'s ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apotea AB (publ) ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Apotea AB (publ)'s ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Apotea AB (publ)'s ROC (Joel Greenblatt) % falls into.


CHIX:APOTES
18GF Score
Apotea AB (publ) CHIX:APOTES
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apotea AB (publ) ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(355.4 + 651.9 + 45.3) - (637.4 + 0 + 151.9)
=263.3

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(371 + 824.3 + 0) - (772.9 + 0 + 212.5)
=209.9

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Apotea AB (publ) for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=409.2/( ( (812.5 + max(263.3, 0)) + (761.9 + max(209.9, 0)) )/ 2 )
=409.2/( ( 1075.8 + 971.8 )/ 2 )
=409.2/1023.8
=39.97 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 39.97% mean?
Apotea AB (publ) (CHIX:APOTES) has a ROC (Joel Greenblatt) % of 39.97% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Apotea AB (publ) and its competitors. This is 22% above median its historical median of 32.86. Over the past decade, Apotea AB (publ)'s ROC (Joel Greenblatt) % has ranged from 7.53 to 40.10. According to the industry distribution chart, Apotea AB (publ) ranks #170 out of 669 companies in the Healthcare Providers & Services industry, placing it in the top 25.4%.
Is Apotea AB (publ)'s ROC (Joel Greenblatt) % too high?
Apotea AB (publ)'s current ROC (Joel Greenblatt) % of 39.97% is 22% above median its 10-year median of 32.86. Over the past 10 years, this metric has ranged from a low of 7.53 to a high of 40.10. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.46. Apotea AB (publ)'s value of 39.97% is 220.8% above this industry median. Based on the distribution chart, Apotea AB (publ) ranks #170 out of 669 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s ROC (Joel Greenblatt) % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Apotea AB (publ) ranks #170 out of 669 companies for ROC (Joel Greenblatt) %. This puts Apotea AB (publ) in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.46. Apotea AB (publ)'s value of 39.97% is 220.8% above this benchmark. Historically, Apotea AB (publ)'s own ROC (Joel Greenblatt) % has ranged from 7.53 to 40.10 over the past decade. While the company's 10-year median is 32.86 vs. the industry median of 12.46, Apotea AB (publ) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.46, based on 669 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apotea AB (publ)'s current ROC (Joel Greenblatt) % of 39.97% is 220.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Apotea AB (publ) and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apotea AB (publ)'s current ROC (Joel Greenblatt) % is 39.97%, which is 22% above median its own 10-year median of 32.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (CHIX:APOTES) has a current ROC (Joel Greenblatt) % of 39.97%. The current ROC (Joel Greenblatt) % is 39.97%, which is 22% above median its 10-year median of 32.86 and 220.8% above the Healthcare Providers & Services industry median of 12.46. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Apotea AB (publ) (CHIX:APOTES), the current ROC (Joel Greenblatt) % is 39.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apotea AB (publ) Business Description

Other Exchanges APOTEA:SwedenV30:Germany
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score

Get the complete analysis for CHIX:APOTES

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr65.20
Price